Palo Alto, California 94304

  • Osteosarcoma

Purpose:

The purpose of this study is to compare whole body magnetic resonance (MR) imaging, whole body positron emission tomography (PET)/MR imaging, and (if available) PET/Computed Tomography (CT) imaging for the diagnosis of tumors in children and young adults. Sensitivities, specificities and diagnostic accuracies of the different imaging modalities will be compared for significant differences.


Criteria:

Inclusion Criteria: - Patients with proven solid tumors or newly diagnosed mass strongly suspected to represent a solid tumor. - We might also include some patients with leukemia if there is concern for a focal lesion in any of their organs. - Participant's parents (if participant is under 18) or the participant (if participant is 18 years or older) must willingly give written informed consent prior to any image transfer to the image registry. Exclusion Criteria: - Patient has contraindications for MRI or PET/MR. This includes patients with cardiac pacemakers or intracranial vascular clips as well as patients with a blood glucose level > 200 mg/dl. - Lack of parental permission (if participant is younger than 18) or lack of informed consent (if participant is at least 18 years of age). - Patient has a CNS primary tumor. - Pregnant women and fetuses


NCT ID:

NCT03458520


Primary Contact:

Principal Investigator
Heike Daldrup-Link, MD
Stanford University

Anne Muehe
Phone: 650-720-8601
Email: amuehe@stanford.edu


Backup Contact:

N/A


Location Contact:

Palo Alto, California 94304
United States

Anne Muehe
Phone: 650-720-8601
Email: amuehe@stanford.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: September 17, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.